The protective effects of BMSA1 and BMSA5-1-1 proteins against Babesia microti infection
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The intracellular parasite Babesia microti is among the most significant species causinghuman babesiosis and is an emerging threat to human health worldwide. Unravelling thepathogenic molecular mechanisms of babesiosis is crucial in developing new diagnosticand preventive methods. This study assessed how priming with B. microti surface antigen1 (BHSA 1) and seroreactive antigen 5-1-1 (BHSA 5-1-1) mediate protection against B. microti infection. The results showed that 500 µg/ml rBMSA1 and rBMSA5-1-1 partiallyinhibited the invasion of B. microti in vitro by 42.0±3.0%, and 48.0±2.1%, respectively. Blood smears revealed that peak infection at 7 days post-infection (dpi) was 19.6%,24.7%, and 46.7% in the rBMSA1, rBmSA5-1-1, compared to the control groups (healthymice infected with B. microti only), respectively. Routine blood tests showed higher whiteblood cell, red blood cell counts, and haemoglobin levels in the 2 groups (BMSA1 andBMSA5 5-1-1) than in the infection control group at 0–28 dpi. Moreover, the 2 groups hadhigher serum interferon-γ, tumor necrosis factor-α and Interleukin-17A levels, and lowerIL-10 levels than the infection control group throughout the study. These 2 potential vaccine candidate proteins partially inhibit in vitro and in vivo B. microti infection and enhancehost immunological response against B. microti infection.
Abstract
The intracellular parasite Babesia microti is among the most significant species causinghuman babesiosis and is an emerging threat to human health worldwide. Unravelling thepathogenic molecular mechanisms of babesiosis is crucial in developing new diagnosticand preventive methods. This study assessed how priming with B. microti surface antigen1 (BHSA 1) and seroreactive antigen 5-1-1 (BHSA 5-1-1) mediate protection against B. microti infection. The results showed that 500 µg/ml rBMSA1 and rBMSA5-1-1 partiallyinhibited the invasion of B. microti in vitro by 42.0±3.0%, and 48.0±2.1%, respectively. Blood smears revealed that peak infection at 7 days post-infection (dpi) was 19.6%,24.7%, and 46.7% in the rBMSA1, rBmSA5-1-1, compared to the control groups (healthymice infected with B. microti only), respectively. Routine blood tests showed higher whiteblood cell, red blood cell counts, and haemoglobin levels in the 2 groups (BMSA1 andBMSA5 5-1-1) than in the infection control group at 0–28 dpi. Moreover, the 2 groups hadhigher serum interferon-γ, tumor necrosis factor-α and Interleukin-17A levels, and lowerIL-10 levels than the infection control group throughout the study. These 2 potential vaccine candidate proteins partially inhibit in vitro and in vivo B. microti infection and enhancehost immunological response against B. microti infection.
참고문헌 (28)
- Vannier E, "Human babesiosis", N Engl J Med, 366(25), pp.2397~2407 (2012)[DOI]
- Esernio Jenssen D, "Transplacental", perinatal babesiosis, 1987, pp.110(4), 570~572
- Fox LM, "Neonatal babesiosis : case report and review of the literature", Pediatr Infect Dis J, 25(2), pp.169~173 (2006)[DOI]
- Gubernot DM, "Transfusion-transmitted babesiosis in the United States : summary of a workshop", Transfusion, 49(12), pp.2759~2771 (2009)[DOI]
- Hunfeld KP, "Babesiosis : recent insights into an ancient disease", Int J Parasitol, 38(11), pp.1219~1237 (2008)[DOI]
- Krause PJ, "Geographical and temporal distribution of babesial infection in Connecticut", J Clin Microbiol, 29(1), pp.1~4 (1991)[DOI]
- Gorenflot A, "Human babesiosis", Ann Trop Med Parasitol, 92(4), pp.489~501 (1998)[DOI]
- Gelfand JA, "Babesiosis", Curr Clin Top Infect Dis, 18, pp.201~216 (1998)
- Magnarelli LA, "Human exposure to a granulocytic Ehrlichia and other tickborne agents in Connecticut", J Clin Microbiol, 36(10), pp.2823~2827 (1998)[DOI]
- Jiang JF, "Epidemiological, clinical, and laboratory characteristics of 48 cases of"Babesia venatorum"infection in China : a descriptive study", Lancet Infect Dis, 15(2), pp.196~203 (2015)[DOI]
- Carcy B, "Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity", Vet Parasitol, 138(1-2), pp.33~49 (2006)[DOI]
- Nathaly Wieser S, "Vaccination against babesiosis using recombinant GPI-anchored proteins", Int J Parasitol, 49(2), pp.175~181 (2019)[DOI]
- Luo Y, "Identification and characterization of a novel secreted antigen 1 of Babesia microti and evaluation of its potential use in enzymelinked immunosorbent assay and immunochromatographic test", Parasitol Int, 60(2), pp.119~125 (2011)[DOI]
- Cornillot E, "A targeted immunomic approach identifies diagnostic antigens in the human pathogen Babesia microti", Transfusion, 56(8), pp.2085~2099 (2016)[DOI]
- Thekkiniath J, "BmGPAC, an Antigen Capture Assay for Detection of Active Babesia microti Infection", J Clin Microbiol, 56(10), pp.e00067-18~ (2018)[DOI]
- Cai YC, "Molecular Characteriz red blood cell ation of Babesia microti Seroreactive Antigen 5-1-1 and Development of Rapid Detection Methods for Anti-B. microti Antibodies in Serum", Acta Trop, 185, pp.371~379 (2018)[DOI]
- Zhang Y, "Proteomic analysis of Plasmodium falciparum schizonts reveals heparinbinding merozoite proteins", J Proteome Res, 12(5), pp.2185~2193 (2013)[DOI]
- Cai YC, "Molecular characterization and immunological evaluation of truncated Babesia microti rhoptry neck protein 2(BmRON2)as a vaccine candidate", Front Immunol, 12, pp.616343~ (2021)[DOI]
- Vogt AM, "Release of sequestered malaria parasites upon injection of a glycosaminoglycan", PLoS Pathogens, 2(9), pp.e100~ (2006)[DOI]
- Boyle MJ, "Interactions with heparin-like molecules during erythrocyte invasion by P. falciparum merozoites", Blood, 115(22), pp.4559~4568 (2010)[DOI]
- Homer MJ, "Babesiosis", Clin Microbiol Rev, 13(3), pp.451~469 (2000)[DOI]
- Sharma P, "LH750 hematology analyzers to identify malaria and dengue and distinguish them from other febrile illnesses", Int J Lab Hematol, 36(1), pp.45~55 (2014)[DOI]
- Yu-Chun C, "Dynamic of routine blood test in BALB", c mice with Babesia microti infection, 2018, pp.30(3), 300~306
- Hemmer RM, "Up-regulation of tumor necrosis factor-alpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate WA1", Parasitol Res, 86(2), pp.121~128 (2000)[DOI]
- Goff WL, "IL-4 and IL-10 inhibition of IFN-gamma-and TNFalpha-dependent nitric oxide production from bovine mononuclear phagocytes exposed to Babesia bovis merozoites", Vet Immunol Immunopathol, 84(3-4), pp.237~251 (2002)[DOI]
- Stich RW, "Stimulation of nitric oxide production in macrophages by Babesia bovis", Infect Immun, 66(9), pp.4130~4136 (1998)[DOI]
- Clawson ML, "Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB", c mice, 2002, pp.70(9), 5304~5306
- Buddle BM, "Identification of immune response correlates for protection against bovine tuberculosis", Vet Immunol Immunopathol, 108(1-2), pp.45~51 (2005)[DOI]